Clinical trial
The Effect of Antipsychotic Medication and the Associated Hyperprolactinemia as Risk Factor for Periodontal Diseases in Schizophrenic Patients: a Cohort Retrospective Study
NCT06040944 is registered in ClinicalTrials.gov with Fayoum University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Antipsychotic Medication and the Associated Hyperprolactinemia as Risk Factor for Periodontal Diseases in Schizophrenic Patients: a Cohort Retrospective Study
- Lead sponsor
- Fayoum University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- November 1, 2022
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.